BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 6281878)

  • 21. The dissociation of tumor-induced weight loss from hypoglycemia in a transplantable pluripotent rat islet tumor results in the segregation of stable alpha- and beta-cell tumor phenotypes.
    Madsen OD; Karlsen C; Nielsen E; Lund K; Kofod H; Welinder B; Rehfeld JF; Larsson LI; Steiner DF; Holst JJ
    Endocrinology; 1993 Nov; 133(5):2022-30. PubMed ID: 8404649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo and in vitro effects of somatostatin and insulin on glucagon release in a human glucagonoma.
    Waeber G; Gomez F; Chaubert P; Temler E; Chapuis G; Boulat O; Nicod P; Haefliger JA
    Clin Endocrinol (Oxf); 1997 May; 46(5):637-42. PubMed ID: 9231061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic studies and glucagon gel filtration pattern before and after surgery in a case of glucagonoma syndrome.
    von Schenck H; Thorell JI; Berg J; Bojs G; Dymling JF; Hallengren B; Ljungberg O; Tibblin S
    Acta Med Scand; 1979; 205(3):155-62. PubMed ID: 218426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and metabolic aspects of glucagonoma.
    Leichter SB
    Medicine (Baltimore); 1980 Mar; 59(2):100-13. PubMed ID: 6987481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucagonoma syndrome. Report of two cases and literature review.
    Binnick AN; Spencer SK; Dennison WL; Horton ES
    Arch Dermatol; 1977 Jun; 113(6):749-54. PubMed ID: 194536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A functional study of a case of glucagonoma exhibiting typical glucagonoma syndrome.
    Fujita J; Seino Y; Ishida H; Taminato T; Matsukura S; Horio T; Imamura S; Naito A; Tobe T; Takahashi K
    Cancer; 1986 Feb; 57(4):860-5. PubMed ID: 2867823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical assessment of an asymptomatic glucagonoma in a patient with hypergastrinemia and marked antral angiodysplasia.
    Weitgasser R; Sungler P; Hauser-Kronberger C; Dietze O; Sattlegger P; Hacker GW
    Appl Immunohistochem Mol Morphol; 2001 Mar; 9(1):92-6. PubMed ID: 11277423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Necrolytic migratory erythema: glucagonoma syndrome. Clinical and histological aspects].
    Wilkinson DS
    Ann Med Interne (Paris); 1984; 135(8):654-7. PubMed ID: 6099068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucagonomas. Ultrastructure and immunocytochemistry.
    Warner TF; Block M; Hafez GR; Mack E; Lloyd RV; Bloom SR
    Cancer; 1983 Mar; 51(6):1091-6. PubMed ID: 6295622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dermatitis, glossitis, stomatitis, cheilitis, anemia and weight loss: a classic presentation of pancreatic glucagonoma.
    Povoski SP; Zaman SA; Ducatman BS; McFadden DW
    W V Med J; 2002; 98(1):12-4. PubMed ID: 11941895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cutaneous and oral changes as the only manifestations of the glucagonoma syndrome.
    Ditty JF; Lang PG
    South Med J; 1982 Feb; 75(2):222-4. PubMed ID: 6277014
    [No Abstract]   [Full Text] [Related]  

  • 32. The glucagonoma syndrome: surgically curable diabetes.
    Higgins GA; Recant L; Fischman AB
    Am J Surg; 1979 Jan; 137(1):142-8. PubMed ID: 215044
    [No Abstract]   [Full Text] [Related]  

  • 33. A malignant tumor of the pancreas producing glucagonoma syndrome: coexistence of glucagon and pancreatic polypeptide (PP) in the tumor cells.
    Bani D; Bani Sacchi T; Biliotti G
    Pancreas; 1989; 4(4):511-9. PubMed ID: 2548179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The glucagonoma syndrome--a not-so-well-known cutaneous paraneoplastic condition. Case report].
    Galle K; Schweiss D
    Hautarzt; 1984 Apr; 35(4):204-9. PubMed ID: 6327570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro and in vivo studies on glucagonoma tissue.
    Berger M; Teuscher A; Halban P; Trimble E; Studer PP; Wollheim CB; Zimmermann-Telschow H; Muller WA
    Horm Metab Res; 1980 Apr; 12(4):144-50. PubMed ID: 6104627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucagonoma syndrome.
    Bloom SR; Polak JM
    Am J Med; 1987 May; 82(5B):25-36. PubMed ID: 2884877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A human pancreatic glucagonoma, ultrastructural, immunocytochemical and radioimmunological investigations (author's transl)].
    Voigt JJ; Hollande E; Pradayrol L; Vinel JP; Gorguet B
    Ann Pathol; 1981; 1(4):287-97. PubMed ID: 6274365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A unique apudoma producing the glucagonoma and gastrinoma syndromes.
    Dawson J; Bloom SR; Cockel R
    Postgrad Med J; 1983 May; 59(691):315-6. PubMed ID: 6878103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular and cellular analysis of a neoplastic pancreatic A cell tumor.
    Drucker DJ; Asa SL; Silverberg J; Brubaker PL
    Cancer; 1990 Apr; 65(8):1762-70. PubMed ID: 1969326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The glucagonoma syndrome in a Chinese man.
    Lee KO; Chan HL; Lee HL
    Ann Acad Med Singap; 1985 Apr; 14(2):312-6. PubMed ID: 2994543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.